Adjuvant Chemoradiation Therapy for Pancreatic Adenocarcinoma: Who Really Benefits?

BACKGROUND: The role of adjuvant chemoradiation therapy (CRT) in pancreatic cancer remains controversial. The primary aim of this study was to determine if CRT improved survival in patients with resected pancreatic cancer in a large, multiinstitutional cohort of patients. STUDY DESIGN: Patients unde...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Merchant, Nipun B, Rymer, Jennifer, Koehler, Elizabeth AS, Ayers, G Daniel, Castellanos, Jason, Kooby, David A, Weber, Sharon H, Cho, Clifford S, Schmidt, C Max, Nakeeb, Atilla, Matos, Jesus M, Scoggins, Charles R, Martin, Robert CG, Kim, Hong Jin, Ahmad, Syed A, Chu, Carrie K, McClaine, Rebecca, Bednarski, Brian K, Staley, Charles A, Sharp, Kenneth, Parikh, Alexander A
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4167601/
https://ncbi.nlm.nih.gov/pubmed/19476845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jamcollsurg.2008.12.020
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars